Marsh & Mclennan (MRSH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $2.96
- EPS estimate
- $2.90
- EPS surprise
- +2.17%
- Revenue surprise
- +1.71%
- Revenue
- $7.4B
- Revenue estimate
- $7.3B
- Reported
- Jul 21, 2026
Marsh McLennan reported Q2 2026 results on July 21, 2026. Earnings per share were $2.96, ahead of the $2.90 estimate by 2.17%. Revenue was $7.4 billion, above the $7.3 billion consensus by 1.71%. Compared with Q2 2025, EPS rose about 9% from $2.72 and revenue rose about 6% from $7.0 billion.
The table shows steady growth with a clear seasonal pattern. By EPS, Q1 is the strongest quarter each year and Q3 the weakest. Q1 2026 set the highs in the table at $3.29 per share and $7.6 billion in revenue. Annual EPS rose from $6.84 in 2022 to $7.98 in 2023, $8.80 in 2024 and $9.75 in 2025. The first half of 2026 adds up to $6.25 per share, about 8% more than the same period a year earlier. Marsh McLennan beat the EPS estimate in all 20 quarters shown, mostly by small margins. Its largest beat was 12.88% in Q3 2023.
The company reported Q3 between October 16 and October 21 in each of the last five years. That points to mid-to-late October 2026 for the next report. In each year shown, Q3 EPS came in below Q2 and was the lowest of the year.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 21, 2026 | $2.90 | $2.96 | +2.17% | $7.4B | SEC |
| Q1 2026 | Apr 16, 2026 | $3.22 | $3.29 | +2.08% | $7.6B | SEC |
| Q4 2025 | Jan 29, 2026 | $1.98 | $2.12 | +7.30% | $6.6B | SEC |
| Q3 2025 | Oct 16, 2025 | $1.78 | $1.85 | +3.73% | $6.4B | SEC |
| Q2 2025 | Jul 17, 2025 | $2.67 | $2.72 | +2.04% | $7.0B | SEC |
| Q1 2025 | Apr 17, 2025 | $3.02 | $3.06 | +1.18% | $7.1B | SEC |
| Q4 2024 | Jan 30, 2025 | $1.76 | $1.87 | +6.39% | $6.1B | SEC |
| Q3 2024 | Oct 17, 2024 | $1.62 | $1.63 | +0.78% | $5.7B | SEC |
| Q2 2024 | Jul 18, 2024 | $2.40 | $2.41 | +0.56% | $6.2B | SEC |
| Q1 2024 | Apr 18, 2024 | $2.80 | $2.89 | +3.17% | $6.5B | SEC |
| Q4 2023 | Jan 25, 2024 | $1.63 | $1.68 | +3.34% | $5.4B | SEC |
| Q3 2023 | Oct 19, 2023 | $1.39 | $1.57 | +12.88% | $5.4B | SEC |
| Q2 2023 | Jul 20, 2023 | $2.12 | $2.20 | +3.96% | $5.9B | SEC |
| Q1 2023 | Apr 20, 2023 | $2.48 | $2.53 | +2.19% | $5.9B | SEC |
| Q4 2022 | Jan 26, 2023 | $1.42 | $1.47 | +3.58% | $5.0B | SEC |
| Q3 2022 | Oct 20, 2022 | $1.15 | $1.18 | +2.66% | $4.8B | SEC |
| Q2 2022 | Jul 21, 2022 | $1.86 | $1.89 | +1.47% | $5.4B | SEC |
| Q1 2022 | Apr 21, 2022 | $2.14 | $2.30 | +7.28% | $5.5B | SEC |
| Q4 2021 | Jan 27, 2022 | $1.34 | $1.36 | +1.32% | $5.1B | SEC |
| Q3 2021 | Oct 21, 2021 | $1.00 | $1.08 | +8.18% | $4.6B | SEC |
Quarterly revenue
Frequently asked questions
When did Marsh & Mclennan (MRSH) last report earnings?
Marsh & Mclennan last reported on Jul 21, 2026, covering fiscal Q2 2026.
Did MRSH beat earnings estimates?
Yes. Marsh & Mclennan reported EPS of $2.96 for Q2 2026 against a $2.90 estimate — a 2.17% beat.
How much revenue did MRSH report last quarter?
Marsh & Mclennan reported $7.4B in revenue for Q2 2026, against a consensus estimate of $7.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.